SAPA-NE 22nd Annual Conference: A New Era in Biotech and Life Science

Saturday, January 23rd, 2021

One Day Free Zoom Webinar (9AM-6PM)

(number of seats are limited)

The event features presentations and panel discussions presented by distinguished speakers/panelists in academic or industry.

Topics include:

1. Breakthrough science and technologies for novel therapies

2. Disruptive innovations for drug discovery and development

3. Development in diagnostic tools and precision medicines

4. Pharmaceutical and biotech investment and global partnership trends

Keynote speakers at the 22nd SAPA-NE Annual Conference 

• Dan Barouch, M.D., Ph.D. Member, National Academy of Medicine; William Bosworth Castle Professor of Medicine, Harvard Medical School; Director, Center for Virology and Vaccine Research, BIDMC; Member, Ragon Institute of MGH, MIT, and Harvard  [Presentation: COVID-19 Vaccine]
• Eric Fischer, Ph.D. Independent Investigator at DFCI Associate Professor at HMS, and Co-Director of the DFCI Center for Protein Degradation [Presentation: Principles of Small Molecule Mediated Ubiquitin Ligase Targeting]
• Robert Flaumenhaft, M.D., Ph.D. Professor, Chief, Division of Hemostasis and Thrombosis, BIDMC, Harvard Medical School [Presentation: The Prothrombotic Transformation of the Endothelium: Relevance to COVID-19]
• John Evans, MBA. Chief Executive Officer and Board Member at Beam Therapeutics, Venture Partner at ARCH Venture Partners [Presentation: Base Editing: A New Platform for Precision Genetic Medicine]
• Jamie Stokes, Ph.D. Principal Research Scientist at Concept Life Sciences [Presentation: Synthesis and Characterisation of Antibody Drug Conjugates]
• Zonghai Li, M.D., Ph.D. Chairman, Chief Executive Officer, Chief Scientific Officer and Founder of CARsgen Therapeutics [Presentation: Strategies to Increase Antitumor Activities of CAR-T Cell Therapy in Solid Tumors]
• Liang Schweizer, Ph.D. Co-founder, President and CEO of HiFiBiO Therapeutics [Presentation: Pioneering “Drug Intelligent Science” – a Novel Single Cell Approach for Drug Discovery and Development]
• Dian Su, Ph.D. Sr. Scientist, Drug Metabolism and Pharmacokinetics at Genentech [Presentation: Pave the Road to Drug the Undruggable: Driving ADC Discovery from the DMPK Perspective]
• Yan Chen, Ph.D. Founder, President and CEO of Elpis Biopharmaceuticals [Presentation: mRNA Display Technologies Enable Rapid Antibody Discovery and Protein Engineering to Harness Immuno-Oncology Therapeutics]
• Alex Li, Ph.D. Managing Director of TF Capital, Board Director of SAPA, Previous President of SAPA-NE  [Presentation:   An Investor View of Life Science Capital Market in China]
• Jamie Stokes, Ph.D. Principal Research Scientist at Concept Life Sciences [Presentation: Synthesis and Characterisation of Antibody Drug Conjugates]
• Aimin Hui, M.D, Ph.D. President of Global R&D, CMO, and Chair of the Scientific Committee of Fosun Pharma [Presentation: Journey of COVID-19 Vaccine- from Ten Years to One Year]
• Julia Ding, Ph.D. Director, Global Process Analytical Development at Bristol Myers Squibb [Presentation: Paving the Way for Real time Product Quality Attribute and Bioprocess Monitoring in Biologics Development]

Fireside Chat: 2021 JP Morgan Recap

• Ambar Boodhoo, EY Americas Life Sciences Strategy and Transactions Leader
• Qingcong Lin, CEO of Biocytogen Boston

Lunch Career Discussion Panelists

• Brad Warsen, Executive Director of Quality for the Devens Cell Therapy Facility at BMS
• Sanchayita Ghose, Ph.D., Executive Director, Head of Global Downstream Bioprocess Development at BMS
• Ji Li, Ph.D., Principle Scientist, Mechanism of Cancer Resistance TRC at BMS
• Chun Shao, Ph.D., Principle Scientist, Process Development Analytics at BMS

Selected speakers from past events:

• Dr. Dudley Herschbach (1986 Nobel Laureate, Prof., Harvard Univ.)
• Dr. Craig Mello (2006 Nobel Laureate, Prof., U Mass)
• Dr. Jack Szostak (2009 Nobel Laureate, Prof., MGH, Harvard Medical School)
• Dr. Bruce Beutler (2011 Nobel Laureate, Prof., UT Southwestern Medical Center)
• Dr. Ken Chien (Prof. Harvard)
• Dr. George Church (Harvard)
• Dr. Christine A. Poon (Vice Chairman, Johnson & Johnson)
• Dr. JC Gutierrez-Ramos (SVP & CSO, Pfizer)
• Dr. John LaMattina (SVP, Pfizer)
• Dr. Robert R. Ruffolo (R&D President, Wyeth)
• Drs. Mark Levick and Karin Briner (VP, Novartis)
• Dr. Kathleen Metters (SVP, Merck)
• Dr. Yong-Jun Liu (Head of Research, Sanofi)
• Dr. Joanne Beck (VP, Shire)
• Dr. Deborah Dunsire (CEO, Millennium)
• Dr. Gunther Winkler (SVP, Biogen-Idec)
• Dr. Andrew Plump (CMSO, Takeda)
• Dr. Richard Murray (CEO, Jounce Therapeutics)
• Dr. Edward Hu (Co-CEO, WUXI AppTec)
• Dr. Gregory Verdine (CEO, Fog Pharmaceuticals & LifeMine Therapeutics)
• Dr. Sridaran Natesan, (VP, Sanofi)
• Dr. Shaun R. Coughlin, (VP,  Novartis)